Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,747,140
+$1,368,578 QoQ
Shares Held
174,714
+339.4% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 316 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Derivatives in BCRX
reported options exposure · as of Dec 31, 2024CallValue
$372,240
CallShares
49,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $151,394,819 across 40 Drug Manufacturers - Specialty & Generic names. BCRX ranks #14 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
633,370 | $45,513,968 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
48,656 | $26,363,280 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
617,308 | $21,402,068 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
140,059 | $8,956,773 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
44,143 | $7,439,861 | |
| 6 | ALKS |
Alkermes plc.
|
115,195 | $6,036,218 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
133,225 | $3,278,667 | |
| 8 | HROW |
Harrow, Inc.
|
73,622 | $3,126,726 |
All Filings in BCRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,747,140 | 174,714 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $378,562 | 39,765 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,941,697 | 1,659,192 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,414,729 | 1,108,660 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,480,956 | 723,321 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $5,736,735 | 764,898 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $372,240 | 49,500 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $2,706,305 | 359,881 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $107,555 | 14,152 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $495,879 | 97,614 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,920,837 | 320,674 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,282,402 | 746,102 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $138,856 | 19,724 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,257,463 | 150,775 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,188,466 | 277,741 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,194,504 | 174,167 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $4,926,910 | 303,008 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $669,869 | 48,366 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $577,350 | 56,770 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $165,054 | 22,155 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $39,216 | 11,400 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $404,466 | 84,972 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $175,146 | 87,573 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||